Non-small Cell Lung Cancer: The Impact of Ethnic Origin on Patients Being Treated Second Line With Pemetrexed - An Observational Study.
Phase of Trial: Phase IV
Latest Information Update: 01 May 2012
At a glance
- Drugs Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 15 Mar 2012 Actual patient numbers amended from 685 to 434 as reported by ClinicalTrials.gov.
- 16 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.